Supernus, Inc. (SUPN) stock
SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.04+0.21 (+0.73%)
Close on Nov 17, 2026Market cap $3.43BP/E 8.1Yield –
Supernus pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Supernus's pe ratio was 10.6× on Nov 11, 2026, against 33.3× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.6× | −24.9 |
| 2025 | Dec 31, 2025 | 35.5× | – |
See a number that looks wrong?